Enlarged adrenal gland in fetus of maternal diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20211113003

Enrollment

126

Registered

2021-11-13

Start date

2021-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fetal adrenal gland size in gestational and pre-gestational diabetic mellitus pregnancy fetal adrenal gland gestational diabetes mellitus pre-gestational diabetic mellitus

Interventions

GDM managed by diet control,GDM managed by insulin,pre-gestational diabetes mellitus

Screening,Screening,Screening

GDMA1,GMA2,PGDM

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: diabetes pregnant women with gestational ages (GA) range between 28 to 36+6 weeks

Exclusion criteria

Exclusion criteria: fetal abnormality of genetic or kidney or adrenal gland incomplete information

Design outcomes

Primary

Measure	Time frame
large fetal adrenal gland in diabetic pregnant women 12 months chi-square	—

Secondary

Measure	Time frame
neonatal outcome in large fetal adrenal gland fetuses 12 months chi-square	—

Countries

Thailand

Contacts

Public ContactNatthida Mekwongtrakarn

Bhumibol Adulyadej Hospital RTAF

m_natthida@hotmail.com0812588470

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026